Vitamin D deficiency in type 1 narcolepsy: a reappraisal.

@article{Dauvilliers2017VitaminDD,
  title={Vitamin D deficiency in type 1 narcolepsy: a reappraisal.},
  author={Yves Dauvilliers and Elisa Evangelista and R{\'e}gis Lopez and Lucie Barateau and Sabine Scholz and Barbara Crastes de Paulet and Bertrand Carlander and Isabelle Jaussent},
  journal={Sleep medicine},
  year={2017},
  volume={29},
  pages={
          1-6
        }
}
OBJECTIVES Narcolepsy type 1 (NT1) is considered to be an immune-mediated disease in which environmental factors, such as vitamin D, might play a major role. The association between NT1 and vitamin D deficiency has previously been reported. The aim of this case-control study was to reassess vitamin D levels in a large clinic-based adult and paediatric population of patients with NT1 by considering several potential confounding factors. METHODS The serum level of 25-hydroxyvitamin D (25OHD… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 29 references

2015;96:136–46. 5 Hallmayer J. Narcolepsy is strongly associated with the T-cell receptor alpha locus

  • narcolepsy. Am J Hum Genet
  • 2015

infection and vaccination

  • RS Liblau, A Vassalli, A Seifinejad
  • Lancet Neurol. 2014;13:600–13
  • 2014

after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine. 2013;31:1246–54

  • M Partinen, O Saarenpää-Heikkilä, I Ilveskoski
  • 2013

pandemic H1N1 vaccination in France

  • M Partinen, BR Kornum, G Plazzi
  • Brain . 2013;136:2486–96
  • 2013

increase in the incidence of childhood narcolepsy in Finland

  • L Wijnans, C Lecomte, C de Vries
  • PloS One. 2012;7:e33536
  • 2012

Similar Papers

Loading similar papers…